117K views · 2.9K reactions | You didn't read the trial I sent you from the New England Journal of Medicine?? The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free: https://nej.md/DrG16 | The New England Journal of Medicine | Facebook

64K views · 1K reactions | Editor-in-Chief Jeffrey M. Drazen, M.D., highlights three of the Notable Articles of 2016 published in the New England Journal of Medicine: incidence of dementia in the Framingham Heart Study, a randomized trial of labor induction in women over 35, and a 10-year outcomes study in men with prostate cancer. Access the collection at nejm.org/nejm-special. | The New England Journal of Medicine | Facebook

88K views · 1K reactions | A 21-month-old boy presented with a 1-day history of a pruritic rash on his left leg. On examination of the left lower leg, an edematous erythematous plaque was pulsating with alternating erythema and blanching in synchrony with his pulse. What is the most likely diagnosis? To submit your diagnosis, click the link: https://nej.md/2Ku5WxD | The New England Journal of Medicine | Facebook

13K views · 86 reactions | NEJM Wrapped 2025 is here. Take a look back at the numbers that went into a year of publishing at the world’s leading medical journal. To discover the 15 articles NEJM editors selected as among the most impactful in advancing clinical practice and patient care this year, download the Notable Articles of 2025: https://nej.md/4peY19S | The New England Journal of Medicine | Facebook

A new look. A familiar feel. The pulse of knowledge. For the pace of today. Announcing the newly redesigned NEJM website. | The New England Journal of Medicine

Check out the latest NEJM Quick Take about genetic testing and prostate cancer. | The New England Journal of Medicine

81K views · 1.9K reactions | For patients with hemophilia, the goal...

Quick Take: Factor VIII Expression after Gene Therapy for Hemophilia A https://nej.md/3cjgD5m | The New England Journal of Medicine